SCHEMBL15726115

SCHEMBL15726115

COCCOc1cc(Br)ccc1OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 2/20 0.54
▸ CCR5 P51681 5/20 0.51
▸ LMNA P02545 3/20 0.50
▸ USP2 O75604 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ SMPD1 P17405 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.48
▸ HTR1A P08908 1/20 0.48
▸ ADRA1D P25100 1/20 0.48
▸ ADRA1A P35348 1/20 0.48
▸ ADRA1B P35368 1/20 0.48
▸ LRRK2 Q5S007 2/20 0.47
▸ HTR2C P28335 1/20 0.47
▸ HTR2B P41595 1/20 0.47
▸ USP28 Q96RU2 1/20 0.47
▸ USP25 Q9UHP3 1/20 0.47
▸ PTGER1 P34995 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20456336 0.93 SLC6A4 (0.53) SLC6A4CCR5LMNAUSP2ALDH1A1
SCHEMBL21042791 0.93 SLC6A4 (0.53) SLC6A4CCR5LMNAUSP2ALDH1A1
SCHEMBL31053305 0.92 SLC6A4 (0.46) SLC6A4CCR5LMNAUSP2ALDH1A1
SCHEMBL31053270 0.92 SLC6A4 (0.46) SLC6A4CCR5LMNAUSP2ALDH1A1
SCHEMBL31644088 0.87 SLC6A4 (0.66) SLC6A4CCR5LMNAALDH1A1RAB9A
SCHEMBL368071 0.87 SLC6A4 (0.66) SLC6A4CCR5LMNAALDH1A1RAB9A
SCHEMBL1516692 0.86 FBP1 (0.44) SLC6A4LMNAALDH1A1RAB9AHTR2C
SCHEMBL31053304 0.86 FBP1 (0.44) SLC6A4LMNAALDH1A1RAB9AHTR2C
SCHEMBL6044498 0.85 LMNA (0.47) SLC6A4CCR5LMNAUSP2ALDH1A1
SCHEMBL1447864 0.84 SLC6A4 (0.59) SLC6A4CCR5ALDH1A1RAB9ASMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8841456-B2 1,5-naphthyridine derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-09-23 — — US disclosed
US-8841456-B2 1,5-naphthyridine derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-09-23 — — US disclosed
US-20140142302-A1 1,5-NAPHTHYRIDINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-05-22 — — US disclosed
US-20140142302-A1 1,5-NAPHTHYRIDINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-05-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140142302-A1 1,5-NAPHTHYRIDINE DERIVATIVE OR SALT THEREOF NRAS, RAF1, KRAS SLC6A4 4096/4885CCR5 3061/4885LMNA 2757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback